| High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment B Naik, N Gupta, R Ojha, S Singh, VK Prajapati, D Prusty International Journal of Biological Macromolecules 160, 1-17, 2020 | 90 | 2020 |
| High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19 R Ojha, N Gupta, B Naik, S Singh, VK Verma, D Prusty, VK Prajapati European Journal of Pharmaceutical Sciences 151, 105375, 2020 | 53 | 2020 |
| Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications B Naik, VSK Mattaparthi, N Gupta, R Ojha, P Das, S Singh, VK Prajapati, ... Journal of Biomolecular Structure and Dynamics 40 (19), 9543-9567, 2022 | 23 | 2022 |
| Asymptomatic malaria infection prevailing risks for human health and malaria elimination D Prusty, N Gupta, A Upadhyay, A Dar, B Naik, N Kumar, VK Prajapati Infection, Genetics and Evolution 93, 104987, 2021 | 14 | 2021 |
| Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach S Singh, HN Banavath, P Godara, B Naik, V Srivastava, D Prusty 3 Biotech 12 (9), 198, 2022 | 13 | 2022 |
| Identification of FDA-approved drugs with triple targeting mode of action for the treatment of monkeypox: a high throughput virtual screening study V Srivastava, B Naik, P Godara, D Das, VSK Mattaparthi, D Prusty Molecular Diversity, 1-15, 2023 | 9 | 2023 |
| Rational designing of peptide-ligand conjugates-based immunotherapy for the treatment of complicated malaria P Godara, B Naik, R Meghwal, R Ojha, V Srivastava, VK Prajapati, ... Life Sciences 311, 121121, 2022 | 7 | 2022 |
| An in‐silico‐based study identified peptide inhibitors that can block the egression of the monkeypox virus by inhibiting the p37 protein target S Singh, V Srivastava, P Godara, HN Banavath, H Tak, A Nayak, ... Peptide Science 115 (5), e24325, 2023 | 2 | 2023 |
| Structure-based virtual screening approach reveals natural multi-target compounds for the development of antimalarial drugs to combat drug resistance B Naik, N Gupta, P Godara, V Srivastava, P Kumar, R Giri, VK Prajapati, ... Journal of Biomolecular Structure and Dynamics, 1-25, 2023 | 2 | 2023 |
| Peptide-ligand conjugate based immunotherapeutic approach for targeted dismissal of non-structural protein 1 of dengue virus: A novel therapeutic solution for mild and severe … V Srivastava, P Godara, SP Jena, B Naik, S Singh, VK Prajapati, D Prusty International Journal of Biological Macromolecules 260, 129562, 2024 | | 2024 |
| Structure-based virtual screening against multiple Plasmodium falciparum kinases reveals antimalarial compounds P Godara, K Reddy, W Sahu, B Naik, V Srivastava, R Das, A Mahor, ... Molecular Diversity, 1-21, 2023 | | 2023 |
